Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P04275: Variant p.Cys1149Arg

von Willebrand factor
Gene: VWF
Feedback?
Variant information Variant position: help 1149 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Cysteine (C) to Arginine (R) at position 1149 (C1149R, p.Cys1149Arg). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and polar (C) to large size and basic (R) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In VWD1; reduced secretion of homodimers and heterodimers with wild type VWD and increased degradation by the proteasome. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 1149 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 2813 The length of the canonical sequence.
Location on the sequence: help SCEERNLRENGYECEWRYNS C APACQVTCQHPEPLACPVQC The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         SCEERNLRENGYECEWRYNSCAPACQVTCQHPEPLACPVQC

                              NCEERNLHENGYECEWRYNSCAPACPITCQHPEPLACPVQC

Mouse                         SCEEKNVRENGYECEWRYNSCAPACPVTCQHPEPLACPVQC
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 764 – 2813 von Willebrand factor
Domain 1146 – 1196 TIL 4
Glycosylation 1147 – 1147 N-linked (GlcNAc...) asparagine; atypical
Disulfide bond 1149 – 1169
Alternative sequence 315 – 2813 Missing. In isoform 2.
Mutagenesis 1149 – 1149 C -> R. Reduced secretion and increased intracellular retention. Similar phenotype; when associated with S-1169.
Mutagenesis 1169 – 1169 C -> S. Reduced secretion and increased intracellular retention. Similar phenotype; when associated with R-1149.
Beta strand 1143 – 1153



Literature citations
Type 1 von Willebrand disease mutation Cys1149Arg causes intracellular retention and degradation of heterodimers: a possible general mechanism for dominant mutations of oligomeric proteins.
Bodo I.; Katsumi A.; Tuley E.A.; Eikenboom J.C.; Dong Z.; Sadler J.E.;
Blood 98:2973-2979(2001)
Cited for: VARIANT VWD1 ARG-1149; MUTAGENESIS OF CYS-1149 AND CYS-1169;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.